GlassScriptPhysician profile
Joel Daniel Kelly
NPI 1669632881
$15,680.14
in general payments reported to CMS, 2019-2025
48 companies · $1,256 in 2025
The $1,256 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,890 · 2020: $3,848 · 2021: $844 · 2022: $1,093 · 2023: $3,570 · 2024: $3,179 · 2025: $1,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,684 · Travel and Lodging: $1,216 · Consulting Fee: $91.79 · Entertainment: $13.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,683.79 |
| Travel and Lodging | $1,215.67 |
| Consulting Fee | $91.79 |
| Entertainment | $13.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $3,407.94 | 2019-2023 | |
| Convatec INC. | $3,243.82 | 2023-2024 | |
| Smith+Nephew, INC. | $2,305.58 | 2019-2025 | Grafix Pl, Stravix Pl, Stravix |
| Epsfl, LLC | $1,849.58 | 2023 | |
| Next Science LLC | $625.99 | 2022-2024 | Blastx, Xperience, Surgx |
| Paratek Pharmaceuticals, INC. | $379.90 | 2022-2025 | Nuzyra |
| Organogenesis INC. | $328.08 | 2019-2025 | Apligraf, Puraply Am |
| Nevro Corp. | $287.00 | 2022-2023 | Senza |
| Amniox Medical, INC. | $269.31 | 2019 | |
| Medtronic, INC. | $202.33 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Lifenet Health | $192.76 | 2025 | Theragenesis Wound Matrix |
| Globus Medical, INC. | $176.28 | 2025 | Senza |
| Osiris Therapeutics INC. | $166.75 | 2019 | |
| Cardiovascular Systems INC. | $166.08 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $157.94 | 2019-2020 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $141.37 | 2019-2020 | |
| Horizon Therapeutics Plc | $138.22 | 2019-2023 | Krystexxa |
| In2bones USA, LLC | $134.24 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $132.37 | 2023-2024 | Jublia |
| Nuo Therapeutics | $129.54 | 2025 | |
| Medela LLC | $104.81 | 2019 | |
| Melinta Therapeutics, LLC | $103.84 | 2019 | |
| Djo, LLC | $99.65 | 2019 | |
| Progenacare Global, LLC | $95.17 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $84.01 | 2024-2025 | |
| Amgen INC. | $74.90 | 2025 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $71.52 | 2022-2023 | Seglentis |
| Surgenex LLC | $64.77 | 2025 | Renograft, Surgraft, Ardeograft |
| Merck Sharp & Dohme LLC | $53.97 | 2019 | |
| Kerecis Limited | $49.88 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Aroa Biosurgery Incorporated | $48.26 | 2019 | |
| Arthrosurface Incorporated | $44.90 | 2019 | |
| Kci USA, INC. | $42.53 | 2019-2022 | |
| Alfasigma USA, INC. | $40.50 | 2021 | |
| Osteocentric Technologies, INC. | $37.85 | 2019 | |
| Acell, INC. | $34.35 | 2019 | |
| Crossroads Extremity Systems, LLC | $28.66 | 2021 | |
| Boston Scientific Corporation | $24.38 | 2024 | |
| Urgo Medical North America, LLC | $21.92 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| Advanced Oxygen Therapy INC. | $17.88 | 2023 | Topical Oxygen Chamber For Extremities |
| Medtronic Vascular, INC. | $16.15 | 2019 | |
| Normatec Industries, LP | $14.33 | 2019 | |
| Polarityte, INC. | $13.45 | 2019 | |
| Novo Nordisk INC | $13.43 | 2019 | |
| Integra Lifesciences Corporation | $13.39 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Grt US Holding, INC. | $13.28 | 2022 | |
| Triad Life Sciences INC. | $12.28 | 2022 | |
| Assertio Therapeutics, INC. | $5.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.